Actuate Therapeutics, Inc. Interest Payable
Actuate Therapeutics, Inc. (ACTU) had Interest Payable of $11.83 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2025-05-15
- 2025-03-31: Interest Payable $11.83K.
- 2024-12-31: Interest Payable $6.77K.
- 2024-09-30: Interest Payable $1.69K.
- 2024-06-30: Interest Payable $70.10K.
| Period end | Interest Payable |
|---|---|
| 2025-03-31 | $11.83K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $6.77K 10-Q · filed 2025-05-15 |
| 2024-09-30 | $1.69K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $70.10K 10-Q · filed 2024-09-24 |
| 2023-12-31 | $130.04K 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |